Suicide gene therapy of chemically induced mammary tumor in rat: efficacy and distant bystander effect

Cancer Res. 1998 Aug 15;58(16):3529-32.

Abstract

We examined the efficacy of suicide gene therapy for nitrosomethylurea-induced mammary tumors in rats. Individual tumors were directly injected with a retrovirus-producing cell line that releases retroviral vectors that transduce the herpes simplex virus type 1 thymidine kinase (HSV1-TK) gene. HSV1-TK specifically converts the nucleoside analogue ganciclovir (GCV) into a toxic metabolite. Compared to control rats receiving saline, we observed a significant tumor regression of the injected tumors following GCV administration, accompanied by a stromal inflammation and an extensive lymphocyte infiltration invading the tumor epithelium. It is noteworthy that the neighboring uninjected tumors also regressed, demonstrating the occurrence of a distant bystander effect. This is the first demonstration that HSV1-TK/GCV can efficiently treat multiple solid tumors directly generated from an epithelial tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimetabolites / metabolism
  • Antimetabolites / therapeutic use*
  • Carcinogens
  • Female
  • Ganciclovir / metabolism
  • Ganciclovir / therapeutic use*
  • Genetic Therapy / methods*
  • Herpesvirus 1, Human / enzymology*
  • Herpesvirus 1, Human / genetics
  • Mammary Neoplasms, Experimental / chemically induced
  • Mammary Neoplasms, Experimental / pathology
  • Mammary Neoplasms, Experimental / therapy*
  • Methylnitrosourea
  • Neoplasms, Multiple Primary / chemically induced
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / therapy
  • Rats
  • Rats, Sprague-Dawley
  • Thymidine Kinase / genetics
  • Thymidine Kinase / metabolism
  • Thymidine Kinase / therapeutic use*
  • Transfection

Substances

  • Antimetabolites
  • Carcinogens
  • Methylnitrosourea
  • Thymidine Kinase
  • Ganciclovir